Google News Alert for: prostate cancer
Prostate cancer gets TV spotlightSioux Falls Argus LeaderTo highlight prostate cancer awareness month, three locally notable men will be having digital rectal examinations on the 6 pm TV news broadcasts Wednesday ...See all stories on this topic
Hundreds Race at Shelby Farms to Raise Awareness of Prostate CancerEyewitness News MemphisMemphis, TN - Hundreds of people gathered at Shelby Farms on Saturday, September 12, 2009 for the Great Prostate Cancer Challenge. ...See all stories on this topic
Southeast Texas Men Concerned About Prostate Cancer Can Get Free ...KBMT ABC 12The Julie Rogers Gift of Life Program is holding free prostate screenings to the medically under-served men in the area in recognition of National Prostate ...See all stories on this topic
Early detection saves lives at the Prostate Cancer Screening and ...KAITRaul Blasini is a thirteen year prostate cancer survivor. Soon after moving to Pocahontas, he saw a need and decided to do something about it. ...See all stories on this topic
Prostate Cancer Caused By a Virus?Ontario NowA discovery of a link between prostate cancer and a virus raises concern that the virus infection may be an indicator of malignant tumors that need ...See all stories on this topic
Obesity may raise prostate cancer riskFood ConsumerA new study shows that body mass in younger and older adulthood and weight gain during these periods may influence a man's risk of prostate cancer although ...See all stories on this topic
Google Blogs Alert for: prostate cancer
Researchers find prostate cancer stem cell « zikkirBy Naiomi Solomon Their findings are only experimental – the stem cells were found in mice – but could explain at least some types of prostate cancer and eventually offer new ways to treat it, they reported today in the journal Nature. ...zikkir - http://zikkir.com/index/
Joe Wilson Funded by Drug Co Lobbyists, Asked for Earmark » PSA ...By jacquie strax Glaxosmithkline makes Avodart, another androgen-blockade drug used preventively, to reduced the risk of prostate cancer, as well as in treatment of recurrence of prostate cancer. Novartis makes Zometa, used to prevent osteoporosis and ...PSA Rising Prostate Cancer Blog - http://psa-rising.com/blog/
Free prostate cancer screenings offered by institute at UAMSThe Winthrop P. Rockefeller Cancer Institute will offer free prostate cancer screenings next week at the University of Arkansas for Medical Sciences. Subscribers must LOG-IN to read this full story. Access is free for print subscribers ...Arkansas Democrat-Gazette stories:... - http://www2.arkansasonline.com/news/subscriber/arkansas/
My Father and his battle with prostate cancer... - Oakland Raiders ...By BK Many of you know that my father has been fighting prostate cancer for the past two years. On Wednesday, I got a call from my mom stating that my.Oakland Raiders Forum Message... - http://www.raiderfans.net/forum/
NAMI NC Heard in the Halls: cpcn.com Prostate Cancer Canada ...By NAMI NC Heard in the Halls cpcn.com Prostate Cancer Canada Canadian Pharmacy Air Canada ... Dr.Natalia. Ca ms nada Pharmacy guar ei antees you the low kas est price on all of your med krw ication(s). If you find your medication(s) cheaper at any other ...NAMI NC Heard in the Halls - http://nami-nc-heard-in-the-halls.blogspot.com/
This once a day Google Alert is brought to you by Google.
Remove this alert. Create another alert. Manage your alerts. =
ReplyReply All
Move...IMPORTANT SAVEDsavesaved
.stop('LD_JS_BP', false);
About Me
- GEORGE M. SUAREZ, M.D.
- Miami, Florida, United States
- I am a board certified Urologist in private practice in Miami, Florida
3 comments:
I've beeen checking around looking to find a physician that can do the Hifu procedure in the US. Why is it so hard? I 'll be writing a letter to Mr. Obama to see what he can do. This is ludicrous. Henry Manzzano
Radiation therapy for prostate cancer raises bladder, rectal cancer risk, study indicates
Tuesday, October 28 2008 | Comments
________________________________________
The risk of developing bladder cancer is higher for men receiving radiotherapy for prostate cancer than those who undergo radical prostatectomy, and the risk of rectal cancer is higher for those receiving external beam radiotherapy than those who undergo radical prostatectomy, according to a recent study.
Prostatectomy and radiation therapy are the 2 most common forms of treatment for prostate cancer, and their success rates for achieving long-term disease-free survival are relatively similar. Radiotherapy, however, does not carry the risks of incontinence and erectile dysfunction associated with radical prostatectomy.
In this retrospective study, 243,082 men 40 years or older who underwent radical prostatectomy or radiotherapy for prostate cancer between 1988 and 2003 were grouped according to type of treatment received: radical prostatectomy (RP; 109,178; 45%); external beam radiotherapy (EBRT; 93,059; 38%); interstitial brachytherapy (BT; 22,889; 9%); or a combination of EBRT and BT (EBRT-BT; 17,956; 7%).
The groups were followed from the time of prostate cancer diagnosis until the development of bladder or rectal cancer, death, or date of last follow-up. Median follow-up time was 49 months (range, 6-191 months).
Compared to radical prostatectomy, the relative risk of developing bladder cancer was 1.88 after EBRT, 1.52 after BT, and 1.85 after EBRT-BT. The relative risk of developing rectal cancer was 1.26 after EBRT, 1.08 after BT, and 1.21 after EBRT-BT.
Patients who had a radical prostatectomy had a standardized incidence ratio (SIR) of bladder cancer nearly identical to the U.S. population (SIR, 0.99; 95% CI, 0.91-1.05). However, subjects in the EBRT (SIR, 1.42; 95% CI, 1.34-1.50) and EBRT-BT cohorts (SIR, 1.39; 95% CI, 1.19-1.64) had higher than expected incidence rates of bladder cancer compared to the U.S. population.
"When we calculated the age adjusted incidence risk ratio, we found that all radiation treatment cohorts had a statistically significant higher risk of bladder cancer developing compared to the radical prostatectomy cohort," the investigators noted. Those at highest risk were those who received EBRT. Only the EBRT cohort had an increased risk of rectal cancer. Patients undergoing EBRT-BT were 3 times more likely to have rectal cancer after 10 years than those treated with radical prostatectomy (HR, 3.25; 95% CI, 1.25, 8.44).
According to the investigators, the results of this study support including the risk of secondary malignancy of the bladder and rectum into the decision-making process for the patient. (Nieder A, et al. J Urol 2008;180:2005-2010.)
Radiation therapy for prostate cancer raises bladder, rectal cancer risk, study indicates
Tuesday, October 28 2008 | Comments
________________________________________
The risk of developing bladder cancer is higher for men receiving radiotherapy for prostate cancer than those who undergo radical prostatectomy, and the risk of rectal cancer is higher for those receiving external beam radiotherapy than those who undergo radical prostatectomy, according to a recent study.
Prostatectomy and radiation therapy are the 2 most common forms of treatment for prostate cancer, and their success rates for achieving long-term disease-free survival are relatively similar. Radiotherapy, however, does not carry the risks of incontinence and erectile dysfunction associated with radical prostatectomy.
In this retrospective study, 243,082 men 40 years or older who underwent radical prostatectomy or radiotherapy for prostate cancer between 1988 and 2003 were grouped according to type of treatment received: radical prostatectomy (RP; 109,178; 45%); external beam radiotherapy (EBRT; 93,059; 38%); interstitial brachytherapy (BT; 22,889; 9%); or a combination of EBRT and BT (EBRT-BT; 17,956; 7%).
The groups were followed from the time of prostate cancer diagnosis until the development of bladder or rectal cancer, death, or date of last follow-up. Median follow-up time was 49 months (range, 6-191 months).
Compared to radical prostatectomy, the relative risk of developing bladder cancer was 1.88 after EBRT, 1.52 after BT, and 1.85 after EBRT-BT. The relative risk of developing rectal cancer was 1.26 after EBRT, 1.08 after BT, and 1.21 after EBRT-BT.
Patients who had a radical prostatectomy had a standardized incidence ratio (SIR) of bladder cancer nearly identical to the U.S. population (SIR, 0.99; 95% CI, 0.91-1.05). However, subjects in the EBRT (SIR, 1.42; 95% CI, 1.34-1.50) and EBRT-BT cohorts (SIR, 1.39; 95% CI, 1.19-1.64) had higher than expected incidence rates of bladder cancer compared to the U.S. population.
"When we calculated the age adjusted incidence risk ratio, we found that all radiation treatment cohorts had a statistically significant higher risk of bladder cancer developing compared to the radical prostatectomy cohort," the investigators noted. Those at highest risk were those who received EBRT. Only the EBRT cohort had an increased risk of rectal cancer. Patients undergoing EBRT-BT were 3 times more likely to have rectal cancer after 10 years than those treated with radical prostatectomy (HR, 3.25; 95% CI, 1.25, 8.44).
According to the investigators, the results of this study support including the risk of secondary malignancy of the bladder and rectum into the decision-making process for the patient. (Nieder A, et al. J Urol 2008;180:2005-2010.)
Post a Comment